Workflow
Hamilton Beach(HBB) - 2025 Q2 - Quarterly Report

Part I. FINANCIAL INFORMATION Item 1. Financial Statements Presents unaudited consolidated financial statements, including balance sheets, operations, cash flows, equity changes, and detailed notes Consolidated Balance Sheets | Metric | June 30, 2025 (in thousands) | Dec 31, 2024 (in thousands) | June 30, 2024 (in thousands) | | :-------------------------------- | :--------------------------- | :-------------------------- | :-------------------------- | | Assets | | | | | Cash and cash equivalents | $11,338 | $45,644 | $37,213 | | Inventory | $160,357 | $124,904 | $130,197 | | Total current assets | $260,106 | $303,719 | $264,992 | | Total assets | $363,804 | $415,067 | $369,896 | | Liabilities & Equity | | | | | Accounts payable | $76,275 | $104,161 | $96,452 | | Revolving credit agreements (non-current) | $50,000 | — | — | | Total current liabilities | $105,492 | $154,120 | $177,645 | | Total liabilities | $199,829 | $249,164 | $224,164 | | Total stockholders' equity | $163,975 | $165,903 | $145,732 | - Total assets decreased by $51.26 million from December 31, 2024, to June 30, 2025, primarily driven by a significant reduction in cash and cash equivalents and trade receivables, partially offset by an increase in inventory7 - Total liabilities decreased by $49.34 million from December 31, 2024, to June 30, 2025, mainly due to a decrease in accounts payable and other current liabilities, while $50.00 million in revolving credit agreements shifted from current to non-current7 Consolidated Statements of Operations | Metric | Three Months Ended June 30, 2025 (in thousands) | Three Months Ended June 30, 2024 (in thousands) | Six Months Ended June 30, 2025 (in thousands) | Six Months Ended June 30, 2024 (in thousands) | | :-------------------------------- | :------------------------------------ | :------------------------------------ | :---------------------------------- | :---------------------------------- | | Revenue | $127,770 | $156,240 | $261,142 | $284,517 | | Gross profit | $35,131 | $40,496 | $67,902 | $70,550 | | Operating profit (loss) | $5,948 | $9,956 | $8,261 | $9,013 | | Net income (loss) | $4,453 | $5,986 | $6,258 | $4,824 | | Basic and diluted EPS | $0.33 | $0.42 | $0.46 | $0.34 | - Revenue for the three months ended June 30, 2025, decreased by 18.2% year-over-year, while net income decreased by 25.6%9 - For the six months ended June 30, 2025, revenue decreased by 8.2% year-over-year, but net income increased by 29.7%, and basic and diluted EPS rose from $0.34 to $0.469 Consolidated Statements of Comprehensive Income (Loss) | Metric | Three Months Ended June 30, 2025 (in thousands) | Three Months Ended June 30, 2024 (in thousands) | Six Months Ended June 30, 2025 (in thousands) | Six Months Ended June 30, 2024 (in thousands) | | :-------------------------------- | :------------------------------------ | :------------------------------------ | :---------------------------------- | :---------------------------------- | | Net income (loss) | $4,453 | $5,986 | $6,258 | $4,824 | | Foreign currency translation adjustment | $2,660 | $(1,868) | $2,987 | $(2,965) | | Cash flow hedging activity | $(1,115) | $1,555 | $(1,735) | $1,592 | | Total other comprehensive income (loss), net of tax | $1,080 | $(1,243) | $355 | $(1,760) | | Comprehensive income (loss) | $5,533 | $4,743 | $6,613 | $3,064 | - Comprehensive income for the three months ended June 30, 2025, increased to $5.53 million from $4.74 million in the prior year, primarily due to a positive shift in foreign currency translation adjustment12 - For the six months ended June 30, 2025, comprehensive income more than doubled to $6.61 million from $3.06 million in the prior year, largely influenced by favorable foreign currency translation adjustments12 Consolidated Statements of Cash Flows | Activity | Six Months Ended June 30, 2025 (in thousands) | Six Months Ended June 30, 2024 (in thousands) | | :-------------------------------- | :------------------------------------ | :------------------------------------ | | Net cash provided by (used for) operating activities | $(23,773) | $37,071 | | Net cash provided by (used for) investing activities | $(1,466) | $(7,347) | | Net cash provided by (used for) financing activities | $(10,549) | $(7,683) | | Increase (decrease) in cash for the period | $(35,186) | $21,789 | | Balance at the end of the period | $11,338 | $38,168 | - Net cash used for operating activities significantly shifted from a positive $37.07 million in H1 2024 to a negative $23.77 million in H1 2025, a year-over-year decline of $60.9 million1483 - Net cash used for investing activities decreased by $5.88 million in H1 2025 compared to H1 2024, primarily due to the absence of the HealthBeacon acquisition in the current period1484 - Net cash used for financing activities increased to $10.55 million in H1 2025 from $7.68 million in H1 2024, driven by increased share repurchases1485 Consolidated Statements of Changes in Equity | Equity Component | Balance, Jan 1, 2025 (in thousands) | Balance, June 30, 2025 (in thousands) | Balance, Jan 1, 2024 (in thousands) | Balance, June 30, 2024 (in thousands) | | :-------------------------------- | :---------------------------------- | :---------------------------------- | :---------------------------------- | :---------------------------------- | | Class A Common Stock | $115 | $118 | $112 | $114 | | Capital in Excess of Par Value | $76,668 | $78,673 | $70,401 | $73,483 | | Treasury Stock | $(26,202) | $(33,549) | $(12,013) | $(16,552) | | Retained Earnings | $123,863 | $126,919 | $99,398 | $101,078 | | Accumulated Other Comprehensive Income (Loss) | $(8,577) | $(8,222) | $(10,667) | $(12,427) | | Total Stockholders' Equity | $165,903 | $163,975 | $147,267 | $145,732 | - Total stockholders' equity decreased slightly from $165.90 million at January 1, 2025, to $163.98 million at June 30, 2025, primarily due to share repurchases and cash dividends, partially offset by net income17 - Treasury stock increased by $7.35 million during the first six months of 2025, reflecting ongoing share repurchase activities17 Notes to Unaudited Consolidated Financial Statements Detailed notes for financial statements, covering accounting policies, transactions, equity, revenue, and segments